CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Regence Oregon

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
C
Index (ASP = 100)
99.9
Vs. acquisition
-2.8%
Brand index
99.8
Biosimilar index
102.5
Contract variability
Low
Drugs observed
705
States
7

Contracts below the typical acquisition benchmark (102.7) on the median drug.

Thin book — treat these figures as indicative, not comparable.

How this payer prices

On this filing, the median drug carries 3 distinct contracted rates across practices, with 93% of billing volume on the single most common rate — a card system — a few standard rates, most practices on the standard one.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.